Antifungal therapy of aspergillus invasive otitis externa: Efficacy of voriconazole and review

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 3, 2009, Pages 1048-1053

  Parize, Perrine ^a   Chandesris, Marie Olivia ^a   Lanternier, Fanny ^a   Poirée, Sylvain ^a   Viard, Jean Paul ^a   Bienvenu, Boris ^b   Mimoun, Michaël ^c   Méchai, Frederic ^a   Mamzer, Marie France ^a   Herman, Philippe ^d   Bougnoux, Marie Elisabeth ^a   Lecuit, Marc ^a,e   Lortholary, Olivier ^a,e  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Hôpital Cochin Saint Vincent de Paul ^*  (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d HÔPITAL LARIBOISIÈRE   (France)

^e INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; CASPOFUNGIN; CEFTAZIDIME; CIPROFLOXACIN; ITRACONAZOLE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OFLOXACIN; PREDNISONE; TACROLIMUS; VORICONAZOLE;

ADULT; ANAMNESIS; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEBRIDEMENT; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TOLERANCE; DRUG WITHDRAWAL; EXTERNAL OTITIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELAPSING POLYCHONDRITIS; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; HUMANS; MALE; MIDDLE AGED; OTITIS EXTERNA; PYRIMIDINES; TEMPORAL BONE; TREATMENT OUTCOME; TRIAZOLES;

EID: 62949185846     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01220-08     Document Type: Article

References (45)

1. Amonoo-Kuofi, K., P. Tostevin, and J. R. Knight. 2005. Aspergillus mastoiditis in a patient with systemic lupus erythematosus: a case report. Skull Base 15:109-112.
2. Bellini, C., P. Antonini, S. Ermanni, M. Dolina, E. Passega, and E. Bernasconi. 2003. Malignant otitis externa due to Aspergillus niger. Scand. J. Infect. Dis. 35:284-288.
3. Bickley, L. S., R. F. Betts, and C. W. Parkins. 1988. Atypical invasive external otitis from Aspergillus. Arch. Otolaryngol. Head Neck Surg. 114:1024-1028.
4. Bryce, G. E., P. Phillips, M. Lepawsky, and M. J. Gribble. 1997. Invasive Aspergillus tympanomastoiditis in an immunocompetent patient. J. Otolaryngol. 26:266-269.
5. Carfrae, M. J., and B. W. Kesser. 2008. Malignant otitis externa. Otolaryngol. Clin. N. Am. 41:537-549.
6. Chandler, J. R. 1968. Malignant external otitis. Laryngoscope 78:1257-1294.
7. Chen, D., A. K. Lalwani, J. W. House, and D. "Choo. 1999. Aspergillus mastoiditis in acquired immunodeficiency syndrome. Am. J. Otol. 20:561- 567.
8. Cunningham, M., V. L. Yu, J, Turner, and H. Curtin. 1988. Necrotizing otitis externa due to Aspergillus in an immunocompetent patient. Arch. Otolaryngol. Head Neck Surg. 114:554-556.
9. Denes, E., A, Boumediene, H. Durox, A. Oksman, F, Saint-Marcoux, M. L. Darde, and J. M. Gaulier. 2007. Voriconazole concentrations in synovial fluid and bone tissues. J. Antimicrob. Chemother. 59:818-819.
10. Denning, D. W., R. M. Tucker, L. H. Hanson, and D. A. Stevens. 1989. Treatment of invasive aspergillosis with itraconazole. Am. J. Med. 86:791- 800.
11. Doroghazi, R. M., J. B. Nadol, Jr., N. E. Hyslop, Jr., A. S. Baker, and L. Axelrod. 1981. Invasive external otitis. Report of 21 cases and review of the literature. Am. J. Med. 71:603-614.
12. Finer, G., D. Greenberg, E. Leibovitz, A. Leiberman, I. Shelef, and J. Kape- lushnik. 2002. Conservative treatment of malignant (invasive) external otitis caused by Aspergillus flavus with oral itraconazole solution in a neutropenic patient. Scand. J. Infect. Dis. 34:227-229.
13. Gordon, G., and N. A. Giddings. 1994. Invasive otitis externa due to Aspergillus species: case report and review. Clin. Infect. Dis. 19:866-870.
14. Gupta, S., J. Koirala, R. Khardori, and N. Khardori. 2007. Infections in diabetes mellitus and hyperglycemia. Infect. Dis. Clin. N. Am. 21:617-638.
15. Hall, P. J., and J. B. Farrior. 1993. Aspergillus mastoiditis. Otolaryngol. Head Neck Surg. 108:167-170.
16. Hanna, E., G. Hughes, I. Eliachar, J. Wanamaker, and W. Tomford. 1993. Fungal osteomyelitis of the temporal bone: a review of reported cases. Ear Nose Throat J. 72:532, 537-541.
17. Harley, W. B., J. S. Dummer, T. L. Anderson, and S. Goodman. 1995. Malignant external otitis due to Aspergillus flavus with fulminant dissemination to the lungs. Clin. Infect. Dis. 20:1052-1054.
18. Herbrecht, R., D. W. Denning, T. F. Patterson, J. E. Bennett, R. E. Greene, J. W. Oestmann, W. V. Kern, K. A. Marr, P. Ribaud, O. Lortholary, R. Sylvester, R. H. Rubin, J. R. Wingard, P. Stark, C. Durand, D. Caillot, E. Thiel, P. H. Chandrasekar, M. R. Hodges, H. T. Schlamm, P. F. Troke, and B. de Pauw. 2002. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N. Engl. J. Med. 347:408-415.
19. Kountakis, S. E., J. V. Kemper, Jr., C. Y. Chang, D. J. DiMaio, and C. M. Stiernberg. 1997. Osteomyelitis of the base of the skull secondary to Aspergillus. Am. J. Otolaryngol. 18:19-22.
20. Lamprecht, J., A. G. Kuhn, and S. Sauer. 1990. Aspergillus mastoiditis in infected granulomatosis-a case report. Laryngorhinootologie 69:341-344.
21. Latgé, J. P. 1999. Aspergillus fumigatus and aspergillosis. Clin. Microbiol. Rev. 12:310-350.
22. Lewis, R. E. 2008. What is the "therapeutic range" for voriconazole? Clin. Infect. Dis. 46:212-214.
23. Ling, S. S., and C. Sader. 2008. Fungal malignant otitis externa treated with hyperbaric oxygen. Int. J. Infect. Dis. 12:550-552.
24. Mardinger, O., D. Rosen, B. Minkow, Z. Tulzinsky, D. Ophir, and A. Hirshberg. 2003. Temporomandibular joint involvement in malignant external otitis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 96:398-403.
25. Menachof, M. R., and R. K. Tackier. 1990. Otogenic skull base osteomyelitis caused by invasive fungal infection. Otolaryngol. Head Neck Surg. 102:285- 289.
26. Mouas, H., I. Lutsar, B. Dupont, O. Fain, R. Herbrecht, F. X. Lescure, and O. Lortholary. 2005. Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases. Clin. Infect. Dis. 40:1141-1147.
27. Muñoz, A., and E, Martinez-Chamorro, 1998. Necrotizing external otitis caused by Aspergillus fumigatus: computed tomography and high resolution magnetic resonance imaging in an AIDS patient. J. Laryngol Otol. 112:98- 102.
28. Narozny, W., J. Kuczkowski, C. Stankiewicz, J. Kot, B. Mikaszewski, and T. Przewozny. 2006. Value of hyperbaric oxygen in bacterial and fungal malignant external otitis treatment. Eur. Arch. Otorhinolaryngol. 263:680-684.
29. Pascual, A., T, Calandra, S. Bolay, T. Buclin, J. Bille, and O, Marchetti. 2008. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin. Infect. Dis. 46:201-211.
30. Petrak, R., J. Pottage, and S. Levin. 1985. Invasive external otitis caused by Aspergillus fumigatus in an immunocompetent patient. J. Infect. Dis. 151: 196.
31. Phillips, J., and S. Jones. 2005. Hyperbaric oxygen as an adjuvant treatment for malignant otitis externa. Cochrane Database Syst. Rev. 18:CD004617. doi:10.1002/14651858.CD004617.pub2.
32. Phillips, P., G. Bryce, J. Shepherd, and D. Mintz. 1990. Invasive external otitis caused by Aspergillus. Rev. Infect. Dis. 12:277-281.
33. Reiss, P., R. Hadderingh, L. J. Schot, and S. A. Danner. 1991. Invasive external otitis caused by Aspergillus fumigatus in two patients with AIDS. AIDS 5:605-606.
34. Ress, B. D., M. Luntz, F. F. Telischi, T. J. Balkany, and M. L. Whiteman. 1997. Necrotizing external otitis in patients with AIDS. Laryngoscope 107: 456-460.
35. Rubin Grandis, J., B. F, Branstetter IV, and V, L. Yu, 2004. The changing face of malignant (necrotising) external otitis: clinical, radiological, and anatomic correlations. Lancet Infect. Dis. 4:34-39.
36. Schwartz, S., and E. Thiel. 1997. Clinical presentation of invasive aspergillosis. Mycoses 40(Suppl. 2):21-24.
37. Shelton, J. C., P. J. Antonelli, and R. Hackett. 2002. Skull base fungal osteomyelitis in an immunocompetent host. Otolaryngol. Head Neck Surg. 126:76-78.
38. Slack, C. L., D. W. Watson, M. J. Abzug, C. Shaw, and K. H. Chan. 1999. Fungal mastoiditis in immunocompromised children. Arch. Otolaryngol. Head Neck Surg. 125:73-75.
39. Smith, J., N. Safdar, V. Knasinski, W. Simmons, S. M. Bhavnani, P. G. Ambrose, and D. Andes. 2006. Voriconazole therapeutic drug monitoring. Antimicrob. Agents Chemother. 50:1570-1572.
40. Sreepada, G. S., and J. A. Kwartler. 2003. Skull base osteomyelitis secondaiy to malignant otitis externa. Curr. Opin. Otolaryngol. Head Neck Surg. 11: 316-323.
41. Stanley, R, J., T. V. McCaffrey, and L. H, Weiland. 1988. Fungal mastoiditis in the immunocompromised host. Arch. Otolaryngol. Head Neck Surg. 114: 198-199.
42. Strauss, M., and E. Fine. 1991. Aspergillus otomastoiditis in acquired immunodeficiency syndrome. Am. J. Otol. 12:49-53.
43. Walsh, T, J., E. J. Anaissie, D. W, Denning, R, Herbrecht, D. P. Kontoyiannis, K. A. Marr, V. A. Morrison, B. H. Segal, W. J. Steinbach, D. A. Stevens, J. A. van Burik, J. R. Wingard, and T. F. Patterson. 2008. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin. Infect. Dis. 46:327-360.
44. Winslow, C. P., A. Diehard, and K. A. McGuire. 2001. Osteomyelitis of the temporomandibular joint. Am. J. Otolaryngol. 22:142-145.
45. Yates, P. D., T. Upile, P. R. Axon, and J. de Carpentier. 1997. Aspergillus mastoiditis in a patient with acquired immunodeficiency syndrome. J. Laryngol. Otol. 111:560-561.